Future studies aimed at clinically validating the efficacy and safety of the polypeptide drug Myr-SIRT2328–339 are essential for demonstrating that SIRT2 inhibition can prevent DA neuronal death in patients with PD. The gene discussed is SIRT2; the disease is Parkinson disease.